SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

UAE Infectious Disease Testing Market 2018 - Test Volume Estimates by Method (Molecular, Serology/Immunodiagnostics, Culture/Microscopy) - ResearchAndMarkets.com
[April 10, 2018]

UAE Infectious Disease Testing Market 2018 - Test Volume Estimates by Method (Molecular, Serology/Immunodiagnostics, Culture/Microscopy) - ResearchAndMarkets.com


The "2018 United Arab Emirates Infectious Disease Testing Market: Supplier Strategies, Test Volume and Sales Forecasts, Technology and Instrumentation Review" report has been added to ResearchAndMarkets.com's offering.

The report reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. mong the main driving forces is continuing spread of AIDS, which remains the world's major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Key Topics


  1. Infectious Diseases Analyzed in the Report
  2. Current and Emerging Products
  3. Technology Review
  4. Opportunities and Strategic Recommendations
  5. Competitive Assessments

Companies Mentioned

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher (News - Alert)
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech/Leica
  • Lonza
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens (News - Alert)
  • Takara Bio
  • Thermo Fisher/Life Technology
  • Wallac/PE
  • Wako

For more information about this report visit https://www.researchandmarkets.com/research/hm7skp/uae_infectious?w=4


[ Back To TMCnet.com's Homepage ]






Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy